AUA 2018 Prostate Cancer
Viewing 57-76 of 109 articles
AUA 2018: Can Free PSA Be Used as a Biomarker in Biochemical Recurrence after Surgery to Predict Castration Resistant Prostate Cancer?
AUA 2018: Risk of Men with Intermediate Risk Prostate Cancer Going On To Definitive Treatment During Active Surveillance: Does a High PSA Predict a Worse Outcome?
AUA 2018: Comparative Genomic Analysis of African American and Non-African American Prostate Cancers: A Report from the Decipher GRID Collaborative
AUA 2018: Impact of Transient ADT with Leuprorelin 11.25 Mg on the Histological Progression of Indolent Prostate Cancer–Results of a Phase III Trial vs Active Surveillance
AUA 2018: Analysis of Methylated DNA Markers for Prediction of Cancer Progression after Radical Prostatectomy
AUA 2018: Four-year Follow-up of a Phase-3 Prospective Randomized Trial of Vascular-Targeted Phototherapy Versus Active Surveillance for Low-Risk Prostate Cancer
AUA 2018: MRI-Guided Transurethral Ultrasound Ablation (TULSA) in Patients with Localized Prostate Cancer: Preliminary Results of TACT Pivotal Study
AUA 2018: Validation of the Decipher Biopsy Test to Predict Adverse Pathology in Men Diagnosed with Low and Favorable Intermediate Risk Prostate Cancer
AUA 2018: Performance Of Quantitative Gleason Grading: A Head to Head Comparison with CAPRA Score and D`Amico Groups